Clinical trial Recruiting at 2 sites Interventional Ages 16 and up

Does a 5-second ventilation pause improve ventilation success in mechanical chest compressions?

Official title: Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression Devices Increase Ventilation Success Rate and Return of Spontaneous Circulation?

Run by Amsterdam UMC, location VUmc · NCT06824961 · Data updated 2026-11-12

This study tests whether increasing the ventilation pause from 3 to 5 seconds during mechanical chest compressions helps ambulance teams deliver two ventilations more reliably during CPR for adults with cardiac arrest.

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment692 (estimated)
SponsorAmsterdam UMC, location VUmc
Academic / other
Locations2 sites (Amsterdam, North Holland and 1 other locations)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedJanuary 15, 2027
Study endsJuly 2027
Registry record updatedAugust 21, 2026
Trial IDNCT06824961 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 16 years or older with out-of-hospital cardiac arrest treated with a LUCAS 3.1 device during an ambulance resuscitation attempt.

Probably not a fit

Patients whose resuscitation involves different devices, settings, or pauses not compatible with the study protocol may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares two settings for a mechanical chest compression device (LUCAS 3.1) during CPR for out-of-hospital cardiac arrest. Participants are adults 16 and older treated by ambulance personnel, with the device configured to either a 3-second or a 5-second pause for ventilations. The primary outcome is the proportion of ventilation pauses in which two ventilations are delivered. The study uses real-world ambulance settings and linked signal data to assess pause integrity and ventilation success. Leading investigators are from Amsterdam UMC (VUmc) with participating ambulance services in Amsterdam and Kennemerland.

Why it matters

Potential benefit: If the 5-second pause improves ventilation delivery, it could enhance CPR effectiveness and increase chances of return of spontaneous circulation.

How similar studies have gone: Prior findings on ventilation pause duration have shown mixed results; this trial tests a specific regulatory pause change that aligns with manual CPR practice, representing a targeted, somewhat novel investigation in mechanical CPR settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥16 years of age)
* OHCA patients with an attempt at cardiopulmonary resuscitation (CPR) by ambulance personnel
* LUCAS® 3.1 has been used during the resuscitation attempt

Exclusion Criteria:

* Missing ambulance run report, missing or unclear impedance signal (measurement of resistance across the thorax), making it impossible to assess the number of ventilation pauses
* Absence of a minimum of 3 assessable pauses intended for ventilation after connecting the LUCAS®

Where it's running

  • Ambulance Amsterdam
    Amsterdam, North Holland, Netherlands
    Recruiting
  • Regionale Ambulance Voorziening Kennemerland - Ambulancezorg GGD Kennemerland
    Haarlem, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.